GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Rhythm Biosciences Ltd (ASX:RHY) » Definitions » PB Ratio
中文

Rhythm Biosciences (ASX:RHY) PB Ratio

: 15.17 (As of Today)
View and export this data going back to 2017. Start your Free Trial

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-04-23), Rhythm Biosciences's share price is A$0.091. Rhythm Biosciences's Book Value per Share for the quarter that ended in Dec. 2023 was A$0.01. Hence, Rhythm Biosciences's PB Ratio of today is 15.17.

The historical rank and industry rank for Rhythm Biosciences's PB Ratio or its related term are showing as below:

ASX:RHY' s PB Ratio Range Over the Past 10 Years
Min: 0   Med: 0   Max: 249.38
Current: 15.17

During the past 6 years, Rhythm Biosciences's highest PB Ratio was 249.38. The lowest was 0.00. And the median was 0.00.

ASX:RHY's PB Ratio is ranked worse than
96.67% of 210 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.08 vs ASX:RHY: 15.17

During the past 12 months, Rhythm Biosciences's average Book Value Per Share Growth Rate was -85.00% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 17.60% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -17.70% per year.

During the past 6 years, the highest 3-Year average Book Value Per Share Growth Rate of Rhythm Biosciences was 17.60% per year. The lowest was -51.50% per year. And the median was -12.10% per year.

Back to Basics: PB Ratio


Rhythm Biosciences PB Ratio Historical Data

The historical data trend for Rhythm Biosciences's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rhythm Biosciences Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
PB Ratio
Get a 7-Day Free Trial 3.08 4.22 108.01 33.11 15.44

Rhythm Biosciences Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 60.70 33.11 24.23 15.44 22.03

Competitive Comparison

For the Diagnostics & Research subindustry, Rhythm Biosciences's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rhythm Biosciences PB Ratio Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, Rhythm Biosciences's PB Ratio distribution charts can be found below:

* The bar in red indicates where Rhythm Biosciences's PB Ratio falls into.



Rhythm Biosciences PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Rhythm Biosciences's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=0.091/0.006
=15.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Rhythm Biosciences  (ASX:RHY) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Rhythm Biosciences PB Ratio Related Terms

Thank you for viewing the detailed overview of Rhythm Biosciences's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Rhythm Biosciences (ASX:RHY) Business Description

Traded in Other Exchanges
Address
30 Flemington Road, Bio21 Institute, Parkville, Melbourne, VIC, AUS, 3010
Rhythm Biosciences Ltd is a medical diagnostics technology company. It is engaged in developing and commercializing Australian medical diagnostics technology for sale to national and international markets. Its product includes ColoSTAT a proposed diagnostic blood test for screening for colorectal cancer. Geographically, the company operates only in Australia.

Rhythm Biosciences (ASX:RHY) Headlines

No Headlines